Clinical trial
A Phase II Study of Fludarabine, Velcade and Rituximab for Relapsed or Refractory Follicular Non-Hodgkin Lymphoma: Hoosier Oncology Group LYM08-134
NCT01186458 is registered in ClinicalTrials.gov with Hoosier Cancer Research Network as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Study of Fludarabine, Velcade and Rituximab for Relapsed or Refractory Follicular Non-Hodgkin Lymphoma: Hoosier Oncology Group LYM08-134
- Lead sponsor
- Hoosier Cancer Research Network
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- October 31, 2010
- Completion date
- October 31, 2013
- Enrollment
- 4 (actual)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.